Evidence map›Paper›PMID 41562402›Full record

ReviewChemistry (Weinheim an der Bergstrasse, Germany)2026

Rational Design Strategies for Stimuli-Responsive DNAzymes Using Modified and Artificial Nucleotides.

Yusuke Takezawa, Mitsuhiko Shionoya

Abstract readReview
In one paragraph

Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yusuke TakezawaChemistry and Materials Program, College of Engineering, Shibaura Institute of Technology, Saitama, Japan.ORCID https://orcid.org/0000-0003-1042-4870
Mitsuhiko ShionoyaResearch Institute for Science and Technology, Tokyo University of Science, Noda-shi, Chiba, Japan.ORCID https://orcid.org/0000-0002-9572-4620

Funding

Amano Institute of TechnologyAsahi Glass FoundationJSPS JP18H02081 JP21H02055 JP22K19100 JP23H04399JSPS JP26248016MEXT JP21H05866MEXT JP23H04399MEXT JP 24H01699
6 · The paper itself

Abstract

DNA, traditionally regarded as genetic material, has emerged as a versatile building block in molecular technology. Catalytic DNA oligomers known as DNAzymes, especially those capable of cleaving target RNA at specific sites, have shown great potential in DNA-based diagnostics, therapeutics, and dynamic DNA nanotechnology. For advanced applications, stimuli-responsive DNAzymes, which are activated only under specific conditions or by specific chemical stimuli, have attracted particular attention. Although such DNAzymes can be obtained by in vitro selection under strictly controlled conditions, more general strategies for their rational design are strongly needed. In this approach, stimuli-responsiveness is introduced into existing DNAzymes by sequence engineering or chemical modification. This review focuses on the rational design of stimuli-responsive RNA-cleaving DNAzymes using modified and artificial nucleotides. Here, we discuss representative strategies, including recent examples: (i) stimulus-induced reconstitution of split DNAzymes, (ii) activity control by strand cleavage or ligation, (iii) blocking of the catalytic core with removable oligonucleotides, (iv) caging with labile protecting groups, and (v) stimuli-induced conformational switching between inactive and active structures. These approaches enable externally controllable activation mechanisms, while maintaining the intrinsic catalytic activity of DNAzymes, providing a valuable toolkit for molecular sensing and DNA nanotechnology.

Indexed as

DNADNA, CatalyticNucleotidesRNACatalysisDNA NanostructuresNanotechnologyNucleic Acid ConformationOligonucleotidesDNADNA, CatalyticNucleotidesOligonucleotidesRNADNADNAzymemodified nucleobaseoligonucleotidesswitching

Identifiers

PMID41562402
PMCPMC13047417

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.